Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 47259 [E6-13433]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 158 / Wednesday, August 16, 2006 / Notices
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Call for Nominations
U.S. Nuclear Regulatory
Commission.
ACTION: Call for nominations.
jlentini on PROD1PC65 with NOTICES
AGENCY:
SUMMARY: The U.S. Nuclear Regulatory
Commission (NRC) is advertising for
nominations for the position of patient
advocate on the Advisory Committee on
the Medical Uses of Isotopes (ACMUI).
DATES: Nominations are due on or
before October 16, 2006.
ADDRESSES: Submit 4 copies of your
resume or curriculum vitae to the Office
of Human Resources, Attn: Ms. Joyce
Riner, Mail Stop: T2D32, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555.
FOR FURTHER INFORMATION CONTACT:
Mohammad S. Saba, Office of Nuclear
Material Safety and Safeguards, U.S.
Nuclear Regulatory Commission,
Washington, DC 20555; telephone: (301)
415–7608; E-mail: mss@nrc.gov.
SUPPLEMENTARY INFORMATION: The
ACMUI advises NRC on policy and
technical issues that arise in the
regulation of the medical use of
byproduct material. Responsibilities
include providing comments on changes
to NRC rules, regulations, and guidance
documents; evaluating certain nonroutine uses of byproduct material;
providing technical assistance in
licensing, inspection, and enforcement
cases; and bringing key issues to the
attention of NRC, for appropriate action.
ACMUI members possess the medical
and technical skills needed to address
evolving issues. The current
membership is comprised of the
following professionals: (a) Nuclear
medicine physician; (b) nuclear
cardiologist; (c) medical physicist in
nuclear medicine unsealed byproduct
material; (d) therapy medical physicist;
(e) radiation safety officer; (f) nuclear
pharmacist; (g) two radiation
oncologists; (h) patients’ rights
advocate; (i) Food and Drug
Administration representative; (j) State
representative; and (k) health care
administrator.
NRC is inviting nominations for the
patient advocate position that is
currently vacant. Committee members
currently serve a 4-year term.
Committee members may be considered
for reappointment to one additional
term.
Nominees must be U.S. citizens and
be able to devote approximately 160
hours per year to Committee business.
Members who are not Federal
employees are compensated for their
service. In addition, members are
reimbursed travel (including per-diem
in lieu of subsistence) and are
reimbursed secretarial and
correspondence expenses. Full-time
Federal employees are reimbursed travel
expenses only.
Security Background Check:
Nominees will undergo a thorough
security background check to obtain the
security clearance that is mandatory for
all ACMUI members. This check will
include a requirement to complete
financial disclosure statements to avoid
conflict-of-interest issues. The security
background check will involve the
completion and submission of
paperwork to NRC, and take
approximately 4 weeks to complete.
Dated at Rockville, Maryland this 10th day
of August, 2006.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E6–13433 Filed 8–15–06; 8:45 am]
BILLING CODE 7590–01–P
OFFICE OF THE UNITED STATES
TRADE REPRESENTATIVES
United States-Chile Free Trade
Agreement: 2005 Annual Product
Review and Tariff Determinations
Office of the United States
Trade Representative.
ACTION: Tariff implementation.
AGENCY:
SUMMARY: This notice announces the
results of the 2005 annual product
review and tariff determinations,
regarding Chilean imports of certain
fruits, vegetables and juices, set forth by
the U.S.-Chile Free Trade Agreement
(FTA). This review determines whether
these tariff free products, imported
during calendar year 2005, have
exceeded conditions elaborated in the
FTA thus requiring the U.S. to impose
duties predetermined by its tariff phaseout schedule. The effective date for the
resulting change in tariff treatment is
October 1, 2006.
FOR FURTHER INFORMATION CONTACT:
Andrew Stephens, Director of Bilateral
Affairs at the Office of the United States
Trade Representatives (USTR), 1724 F
Street, NW., Washington, DC 20508,
(202) 395–6127 or
Andrew_Stephens@ustr.eop.gov.
The U.S.Chile FTA authorizes the duty-free
importation of designated products
provided that import values do not meet
or exceed conditions elaborated in
Chapter 3, Annex 3.3 of the U.S. General
Notes under Note 17 and 18. The
conditions are met when products
exceed fifty percent of total U.S imports
for that specific tariff line or the value
of imports from Chile for a specific tariff
line exceeds $110 million. If either
condition is met, the applied
preferential rate shall revert to duties set
forth according to the staging categories
in the Chapter 3, Annex 3.3 of the FTA
Text. The specific products for which
these conditions apply and the location
of the tariff can be found in Chapter 99,
Note 19 and 20 of the 2006 U.S.
Harmonized Tariff Schedule. These
products include cucumbers, gherkins,
strawberries, blackberries, mulberries,
currants, peppers, vegetable mixes,
certain parts of plants, apple puree,
quince puree and pear puree, apricot
pulp and certain fruit and vegetable
juices.
Since implementation of the U.S.Chile FTA in 2004, the U.S. Trade
Representative’s Office has monitored
Chilean imports to ensure that the
provisions of the FTA have been
implemented correctly. The review of
imports made during the calendar year
2005 found that total U.S. imports of
apple, quince and pear pastes and
purees (HTS 2007.99.4800) equaled $2.2
million and imports from Chile
accounted for more than $1.2 million of
that total. Thus total Chilean imports
accounted for 54 percent of the total,
exceeding the aforementioned
conditions allowed for immediate dutyfree imports under U.S.-Chile FTA
provisions.
Accordingly, the tariff treatment set
forth in subheading 9911.77.11 for
goods of Chile, under the terms of
general note 26 to the HTS, is deleted,
effective with respect to goods that are
entered, or withdrawn from warehouse
for consumption, on or after October 1,
2006, and the rate of duty set forth in
subheading 9911.77.12, together with
scheduled staged reductions thereof,
shall apply to eligible entries of the
subject goods as of October 1, 2006.
SUPPLEMENTARY INFORMATION:
Column A
HTS
Product
Apple, quince and pear pastes and purees ............................................................................................................
VerDate Aug<31>2005
20:24 Aug 15, 2006
Jkt 208001
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
47259
E:\FR\FM\16AUN1.SGM
16AUN1
2007.99.48
Column B
HTS
9911.77.11
]]>Agencies
[Federal Register Volume 71, Number 158 (Wednesday, August 16, 2006)]
[Notices]
[Page 47259]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13433]
[[Page 47259]]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Call for
Nominations
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Call for nominations.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising
for nominations for the position of patient advocate on the Advisory
Committee on the Medical Uses of Isotopes (ACMUI).
DATES: Nominations are due on or before October 16, 2006.
ADDRESSES: Submit 4 copies of your resume or curriculum vitae to the
Office of Human Resources, Attn: Ms. Joyce Riner, Mail Stop: T2D32,
U.S. Nuclear Regulatory Commission, Washington, DC 20555.
FOR FURTHER INFORMATION CONTACT: Mohammad S. Saba, Office of Nuclear
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission,
Washington, DC 20555; telephone: (301) 415-7608; E-mail: mss@nrc.gov.
SUPPLEMENTARY INFORMATION: The ACMUI advises NRC on policy and
technical issues that arise in the regulation of the medical use of
byproduct material. Responsibilities include providing comments on
changes to NRC rules, regulations, and guidance documents; evaluating
certain non-routine uses of byproduct material; providing technical
assistance in licensing, inspection, and enforcement cases; and
bringing key issues to the attention of NRC, for appropriate action.
ACMUI members possess the medical and technical skills needed to
address evolving issues. The current membership is comprised of the
following professionals: (a) Nuclear medicine physician; (b) nuclear
cardiologist; (c) medical physicist in nuclear medicine unsealed
byproduct material; (d) therapy medical physicist; (e) radiation safety
officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h)
patients' rights advocate; (i) Food and Drug Administration
representative; (j) State representative; and (k) health care
administrator.
NRC is inviting nominations for the patient advocate position that
is currently vacant. Committee members currently serve a 4-year term.
Committee members may be considered for reappointment to one additional
term.
Nominees must be U.S. citizens and be able to devote approximately
160 hours per year to Committee business. Members who are not Federal
employees are compensated for their service. In addition, members are
reimbursed travel (including per-diem in lieu of subsistence) and are
reimbursed secretarial and correspondence expenses. Full-time Federal
employees are reimbursed travel expenses only.
Security Background Check: Nominees will undergo a thorough
security background check to obtain the security clearance that is
mandatory for all ACMUI members. This check will include a requirement
to complete financial disclosure statements to avoid conflict-of-
interest issues. The security background check will involve the
completion and submission of paperwork to NRC, and take approximately 4
weeks to complete.
Dated at Rockville, Maryland this 10th day of August, 2006.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E6-13433 Filed 8-15-06; 8:45 am]
BILLING CODE 7590-01-P
